Alcohol interaction trial enhanced with responsive, collaborative approach, says CRO

By Melissa Fassbender contact

- Last updated on GMT

(Image: Getty/OlegEvseev)
(Image: Getty/OlegEvseev)

Related tags: Clinical trial, Contract research organization, Clinical research

Vince & Associates Clinical Research is conducting a Phase Ib alcohol interaction study of Amygdala Neurosciences’ ANS-6637 for the potential treatment of substance abuse.

An Altasciences company, Vince & Associates Clinical Research is a contract research organization (CRO) based in Overland Park, KS.

The proof-of-concept, dose-ranging study will evaluate the safety of the co-administration of ascending doses of ANS-6637 and ethanol in healthy male alcohol drinkers, according to the company.

Amygdala Neurosciences Inc. acquired ANS-6637 (previously GS-6637) from Gilead Sciences, Inc. earlier this year. Its potential clinical indication is the treatment of substance abuse, including alcohol and cocaine dependence.

As for the challenges of conducting the trial, Bradley Vince, D.O., CEO and medical director at Vince & Associates Clinical Research told us the study requires “significant investigator and clinical operations staffing secondary to the necessary safety monitoring and medical hypervigilance​.”

Additionally, recruitment will also be a challenge – as it is across the industry – though specifically, the alcohol interaction trial will require recruitment of qualified volunteers that meet protocol specified eligibility with respect to alcohol consumption history, Vince explained.

It is imperative to utilize a CRO with significant expertise in special populations as well as depth in the Investigator staff secondary to the extensive medical procedures required in alcohol interaction trials​,” he added.

Further, a responsive and collaborative approach by the sponsor with respect to dose escalations further enhances the successful study conduct of these complex clinical trials​,” said Vince.

The CRO has completed five of six dosing cohorts.

Related topics: Clinical Development, Phase I-II

Related news

Show more

Related products

show more

Laboratory Solutions for COVID-19 Clinical Trials

Laboratory Solutions for COVID-19 Clinical Trials

Q2 Solutions | 10-Jun-2020 | Clinical Study

As a leading laboratory services organization for trials across the globe, we are proud to partner with clients to support COVID-19 clinical trials. Our...

Parents as Gatekeepers for Children with Cancer

Parents as Gatekeepers for Children with Cancer

PRA Health Sciences | 08-Jun-2020 | Technical / White Paper

The RACE for Children Act will require new drugs intended for adult cancer treatment to also be studied in pediatric cancers when the molecular target...

Related suppliers

Follow us


View more